Topic

pneumococcal conjugate vaccine candidate

1 article

Pfizer announces positive top-Line results from Phase 3 study of 20-Valent pneumococcal conjugate vaccine in infants
Global News 12 Aug 2022

Pfizer announces positive top-Line results from Phase 3 study of 20-Valent pneumococcal conjugate vaccine in infants

Pfizer plans to submit an sBLA by the end of this year, subject to discussions with US FDA Pfizer announced…